Ambrx

Ambrx, Inc. is a clinical-stage biopharmaceutical company that specializes in the development of next-generation antibody-drug conjugates (ADCs). Their proprietary expanded genetic code technology platform allows for the incorporation of synthetic amino acids into proteins within living cells. This technology enables site-specific, homogenous, and stable conjugation, overcoming limitations of traditional conjugation approaches and leading to optimized molecules designed to improve ADC safety and efficacy.

Their focused portfolio of clinical and preclinical programs targets various cancer indications. Ambrx has a history of collaborations with multiple pharmaceutical companies to develop ADCs for various therapeutic areas, including their lead product candidate ARX517, a prostate-specific membrane antigen (PSMA) targeting ADC, and ARX788, a HER2 targeting ADC. The company was recently acquired by Johnson & Johnson.

Ambrx provides a flexible work environment that fosters a sense of balance between professional and personal lives. The company offers a Total Rewards experience that includes competitive options in the areas of financial/savings, time off, health & well-being, life, work & family, and other benefits. This commitment to employee well-being highlights Ambrx's dedication to creating a positive work environment that supports its employees' needs and allows them to thrive.

Ambrx values its employees and offers a comprehensive benefits package designed to enrich their lives. The company provides competitive options in several key areas including rewards and recognition, financial savings, time off, health and well-being, life, work and family, and other benefits. This total rewards experience aims to engage and empower employees, providing them with the support needed to save, perform, grow, and build a secure future.

Ambrx is a clinical-stage biopharmaceutical company dedicated to discovering and developing a pipeline of next-generation antibody drug conjugates (ADCs) designed to treat cancers with a high unmet medical need. They leverage their proprietary expanded genetic code technology platform, which enables the incorporation of synthetic amino acids into proteins within living cells, to create more stable and effective ADCs. Their focus is on developing innovative and targeted treatment options for patients battling cancer, with a mission to improve their lives with high-quality solutions.

Ambrx fosters a culture that values innovation, practicality, and accountability. They encourage fearless creativity and adaptability, while maintaining integrity and a solution-oriented approach. They promote trust and respect among individuals and teams, prioritize urgency in delivering high-quality products, and encourage their employees to enjoy the journey of discovery and development.

Ambrx values a culture of innovation, practicality, and accountability, which extends to fostering diversity, equity, and inclusion within their workforce. They recognize the importance of a diverse team with qualified backgrounds, providing them with the technology, resources, and facilities needed to address global health challenges. Ambrx embraces innovative ideas and supports the professional growth of their staff, fostering a collaborative environment where the brightest minds can thrive.